Based on the Zepp Health Corp stock forecast from 1 analysts, the average analyst target price for Zepp Health Corp is USD 14.65 over the next 12 months. Zepp Health Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Zepp Health Corp is Slightly Bearish, which is based on 4 positive signals and 7 negative signals. At the last closing, Zepp Health Corp’s stock price was USD 3.13. Zepp Health Corp’s stock price has changed by +8.30% over the past week, +11.99% over the past month and -51.09% over the last year.
No recent analyst target price found for Zepp Health Corp
No recent average analyst rating found for Zepp Health Corp
Company Overview Zepp Health Corp
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China. Read Less
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys...Read More
Frequently Asked Questions About Zepp Health Corp (ZEPP) Stock
Based on ratings from 1 analysts Zepp Health Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on ZEPP's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for ZEPP is USD 14.65 over the next 12 months. The maximum analyst target price is USD 14.65 while the minimum anlayst target price is USD 14.65.
ZEPP stock's Price/Earning ratio is 10.39.
Our analysis grades ZEPP stock's Price / Earning ratio at A+. This means that ZEPP stock's Price/Earning ratio is above 0% of the stocks in the Consumer Electronics sector in the NYE exchange.
Based on this ZEPP may be undervalued for its sector.
The last closing price of ZEPP's stock was USD 3.13.
The most recent market capitalization for ZEPP is USD 0.05B.
Based on targets from 1 analysts, the average taret price for ZEPP is projected at USD 14.65 over the next 12 months.
This means that ZEPP's stock price may go up by +368.05% over the next 12 months.
We can't find any ETFs which contains Zepp Health Corp's stock.
As per our most recent records Zepp Health Corp has 839 Employees.
Zepp Health Corp's registered address is Building B2, Hefei, China, 230088.
You can get more information about it from Zepp Health Corp's website at https://www.huami.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Zepp Health Corp (ZEPP) Stock
Based on ratings from 1 analysts Zepp Health Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on ZEPP's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for ZEPP is USD 14.65 over the next 12 months. The maximum analyst target price is USD 14.65 while the minimum anlayst target price is USD 14.65.
ZEPP stock's Price/Earning ratio is 10.39.
Our analysis grades ZEPP stock's Price / Earning ratio at A+. This means that ZEPP stock's Price/Earning ratio is above 0% of the stocks in the Consumer Electronics sector in the NYE exchange.
Based on this ZEPP may be undervalued for its sector.
The last closing price of ZEPP's stock was USD 3.13.
The most recent market capitalization for ZEPP is USD 0.05B.
Based on targets from 1 analysts, the average taret price for ZEPP is projected at USD 14.65 over the next 12 months.
This means that ZEPP's stock price may go up by +368.05% over the next 12 months.
We can't find any ETFs which contains Zepp Health Corp's stock.
As per our most recent records Zepp Health Corp has 839 Employees.
Zepp Health Corp's registered address is Building B2, Hefei, China, 230088.
You can get more information about it from Zepp Health Corp's website at https://www.huami.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ZEPP !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
